

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The effects of testosterone replacement therapy... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-217/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-217" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The effects of testosterone replacement therapy on the prostate: a clinical perspective" />
    
            <meta name="og:title" content="F1000Research Article: The effects of testosterone replacement therapy on the prostate: a clinical perspective.">
            <meta name="og:description" content="Read the latest article version by Saiful Miah, Tharu Tharakan, Kylie A Gallagher, Taimur T Shah, Mathias Winkler, Channa N Jayasena, Hashim U Ahmed, Suks Minhas, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="18031">
            <meta name="article-id" content="16497">
            <meta name="dc.title" content="The effects of testosterone replacement therapy on the prostate: a clinical perspective">
            <meta name="dc.description" content="Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of androgen deficiency and has reached global proportions. As clinicians, we must be well versed and provide appropriate counseling for men prior to the commencement of testosterone replacement therapy. This review summarizes the current clinical and basic science evidence in relation to this commonly encountered clinical scenario. There is gathering evidence that suggests, from an oncological perspective, that it is safe to commence testosterone replacement therapy for men who have a combination of biochemically confirmed androgen deficiency and who have either had definitive treatment of their prostate cancer or no previous history of this disease. However, patients must be made aware and cautioned that there is a distinct lack of level 1 evidence. Calls for such studies have been made throughout the urological and andrological community to provide a definitive answer. For those with a diagnosis of prostate cancer that remains untreated, there is a sparsity of evidence and therefore clinicians are &ldquo;pushing the limits&rdquo; of safety when considering the commencement of testosterone replacement therapy.">
            <meta name="dc.subject" content="Prostate cancer, testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause">
            <meta name="dc.creator" content="Miah, Saiful">
            <meta name="dc.creator" content="Tharakan, Tharu">
            <meta name="dc.creator" content="Gallagher, Kylie A">
            <meta name="dc.creator" content="Shah, Taimur T">
            <meta name="dc.creator" content="Winkler, Mathias">
            <meta name="dc.creator" content="Jayasena, Channa N">
            <meta name="dc.creator" content="Ahmed, Hashim U">
            <meta name="dc.creator" content="Minhas, Suks">
            <meta name="dc.date" content="2019/02/25">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16497.1">
            <meta name="dc.source" content="F1000Research 2019 8:217">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Prostate cancer">
            <meta name="prism.keyword" content="testosterone replacement therapy">
            <meta name="prism.keyword" content="late onset hypogonadism">
            <meta name="prism.keyword" content="androgen deprivation">
            <meta name="prism.keyword" content="andropause">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/02/25">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="217">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16497.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-217">
            <meta name="citation_title" content="The effects of testosterone replacement therapy on the prostate: a clinical perspective">
            <meta name="citation_abstract" content="Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of androgen deficiency and has reached global proportions. As clinicians, we must be well versed and provide appropriate counseling for men prior to the commencement of testosterone replacement therapy. This review summarizes the current clinical and basic science evidence in relation to this commonly encountered clinical scenario. There is gathering evidence that suggests, from an oncological perspective, that it is safe to commence testosterone replacement therapy for men who have a combination of biochemically confirmed androgen deficiency and who have either had definitive treatment of their prostate cancer or no previous history of this disease. However, patients must be made aware and cautioned that there is a distinct lack of level 1 evidence. Calls for such studies have been made throughout the urological and andrological community to provide a definitive answer. For those with a diagnosis of prostate cancer that remains untreated, there is a sparsity of evidence and therefore clinicians are &ldquo;pushing the limits&rdquo; of safety when considering the commencement of testosterone replacement therapy.">
            <meta name="citation_description" content="Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of androgen deficiency and has reached global proportions. As clinicians, we must be well versed and provide appropriate counseling for men prior to the commencement of testosterone replacement therapy. This review summarizes the current clinical and basic science evidence in relation to this commonly encountered clinical scenario. There is gathering evidence that suggests, from an oncological perspective, that it is safe to commence testosterone replacement therapy for men who have a combination of biochemically confirmed androgen deficiency and who have either had definitive treatment of their prostate cancer or no previous history of this disease. However, patients must be made aware and cautioned that there is a distinct lack of level 1 evidence. Calls for such studies have been made throughout the urological and andrological community to provide a definitive answer. For those with a diagnosis of prostate cancer that remains untreated, there is a sparsity of evidence and therefore clinicians are &ldquo;pushing the limits&rdquo; of safety when considering the commencement of testosterone replacement therapy.">
            <meta name="citation_keywords" content="Prostate cancer, testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Saiful Miah">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author_institution" content="Division of Surgery and Interventional Science, University College London Medical School, 21 University Street, London, WC1E 6AU, UK">
            <meta name="citation_author" content="Tharu Tharakan">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author" content="Kylie A Gallagher">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author" content="Taimur T Shah">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author_institution" content="Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK">
            <meta name="citation_author" content="Mathias Winkler">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author" content="Channa N Jayasena">
            <meta name="citation_author_institution" content="Section of Investigative Medicine, Department of Medicine, Imperial College London, London, W12 0NN, UK">
            <meta name="citation_author" content="Hashim U Ahmed">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_author_institution" content="Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK">
            <meta name="citation_author" content="Suks Minhas">
            <meta name="citation_author_institution" content="Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK">
            <meta name="citation_publication_date" content="2019/02/25">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="217">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16497.1">
            <meta name="citation_firstpage" content="217">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-217/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-217.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=18031 /> <input type=hidden id=articleId name=articleId value=16497 /> <input type=hidden id=xmlUrl value="/articles/8-217/v1/xml"/> <input type=hidden id=xmlFileName value="-8-217-v1.xml"> <input type=hidden id=article_uuid value=8a9eb659-9a77-4cbf-96cf-7e33010675e4 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The effects of testosterone replacement therapy on the prostate: a clinical perspective"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16497.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16497.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-217"
  },
  "headline": "The effects of testosterone replacement therapy on the prostate: a clinical perspective",
  "datePublished": "2019-02-25T10:03:47",
  "dateModified": "2019-02-25T10:03:47",
  "author": [
    {
      "@type": "Person",
      "name": "Saiful Miah"
    },    {
      "@type": "Person",
      "name": "Tharu Tharakan"
    },    {
      "@type": "Person",
      "name": "Kylie A Gallagher"
    },    {
      "@type": "Person",
      "name": "Taimur T Shah"
    },    {
      "@type": "Person",
      "name": "Mathias Winkler"
    },    {
      "@type": "Person",
      "name": "Channa N Jayasena"
    },    {
      "@type": "Person",
      "name": "Hashim U Ahmed"
    },    {
      "@type": "Person",
      "name": "Suks Minhas"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of androgen deficiency and has reached global proportions. As clinicians, we must be well versed and provide appropriate counseling for men prior to the commencement of testosterone replacement therapy. This review summarizes the current clinical and basic science evidence in relation to this commonly encountered clinical scenario. There is gathering evidence that suggests, from an oncological perspective, that it is safe to commence testosterone replacement therapy for men who have a combination of biochemically confirmed androgen deficiency and who have either had definitive treatment of their prostate cancer or no previous history of this disease. However, patients must be made aware and cautioned that there is a distinct lack of level 1 evidence. Calls for such studies have been made throughout the urological and andrological community to provide a definitive answer. For those with a diagnosis of prostate cancer that remains untreated, there is a sparsity of evidence and therefore clinicians are &ldquo;pushing the limits&rdquo; of safety when considering the commencement of testosterone replacement therapy."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-217/v1",
            "name": "The effects of testosterone replacement therapy on the prostate: a..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The effects of testosterone replacement therapy on the prostate: a... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=18031 data-id=16497 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16497.1" data-recommended="" data-doi="10.12688/f1000research.16497.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-217/v1/pdf?article_uuid=8a9eb659-9a77-4cbf-96cf-7e33010675e4" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16497-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16497-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16497-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Miah S, Tharakan T, Gallagher KA <em>et al.</em> The effects of testosterone replacement therapy on the prostate: a clinical perspective [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):217 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16497.1" target=_blank>https://doi.org/10.12688/f1000research.16497.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16497-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16497 id=track-article-signin-16497 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16497?target=/articles/8-217/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18031 /> <input name=articleId type=hidden value=16497 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The effects of testosterone replacement therapy on the prostate: a clinical perspective</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:saiful.miah@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Saiful Miah</span></a><a href="https://orcid.org/0000-0001-5777-518X" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5777-518X</div><sup>1,2</sup>,&nbsp;</span><span class="">Tharu Tharakan<a href="https://orcid.org/0000-0003-1010-7576" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1010-7576</div><sup>1</sup>,&nbsp;</span><span class="">Kylie A Gallagher<sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Taimur T Shah<sup>1,3</sup>,&nbsp;</span><span class=article-page-hidden-authors>Mathias Winkler<sup>1</sup>,&nbsp;</span><span class="">Channa N Jayasena<sup>4</sup>,&nbsp;</span><span class="">Hashim U Ahmed<sup>1,3</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:saiful.miah@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Saiful Miah</span></a><a href="http://orcid.org/0000-0001-5777-518X" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5777-518X</div><sup>1,2</sup>,&nbsp;</span><span class="">Tharu Tharakan<a href="http://orcid.org/0000-0003-1010-7576" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1010-7576</div><sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Kylie A Gallagher<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Taimur T Shah<sup>1,3</sup>,&nbsp;</span><span class=article-page-hidden-authors>Mathias Winkler<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Channa N Jayasena<sup>4</sup>,&nbsp;</span><span class="">Hashim U Ahmed<sup>1,3</sup>,&nbsp;</span><span class="">Suks Minhas<sup>1</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 25 Feb 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16497.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK<br/> <sup>2</sup> Division of Surgery and Interventional Science, University College London Medical School, 21 University Street, London, WC1E 6AU, UK<br/> <sup>3</sup> Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK<br/> <sup>4</sup> Section of Investigative Medicine, Department of Medicine, Imperial College London, London, W12 0NN, UK<br/> <p> <div class=margin-bottom> Saiful Miah <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Tharu Tharakan <br/> <span>Roles: </span> Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Kylie A Gallagher <br/> <span>Roles: </span> Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Taimur T Shah <br/> <span>Roles: </span> Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mathias Winkler <br/> <span>Roles: </span> Methodology, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Channa N Jayasena <br/> <span>Roles: </span> Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Hashim U Ahmed <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Formal Analysis, Methodology, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27265-44695></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15921-44696></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of androgen deficiency and has reached global proportions. As clinicians, we must be well versed and provide appropriate counseling for men prior to the commencement of testosterone replacement therapy. This review summarizes the current clinical and basic science evidence in relation to this commonly encountered clinical scenario. There is gathering evidence that suggests, from an oncological perspective, that it is safe to commence testosterone replacement therapy for men who have a combination of biochemically confirmed androgen deficiency and who have either had definitive treatment of their prostate cancer or no previous history of this disease. However, patients must be made aware and cautioned that there is a distinct lack of level 1 evidence. Calls for such studies have been made throughout the urological and andrological community to provide a definitive answer. For those with a diagnosis of prostate cancer that remains untreated, there is a sparsity of evidence and therefore clinicians are “pushing the limits” of safety when considering the commencement of testosterone replacement therapy. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Prostate cancer, testosterone replacement therapy, late onset hypogonadism, androgen deprivation, andropause </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Saiful Miah (<a href="mailto:saiful.miah@nhs.net">saiful.miah@nhs.net</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Saiful Miah </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Miah S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Miah S, Tharakan T, Gallagher KA <em>et al.</em> The effects of testosterone replacement therapy on the prostate: a clinical perspective [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):217 (<a href="https://doi.org/10.12688/f1000research.16497.1" target=_blank>https://doi.org/10.12688/f1000research.16497.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 25 Feb 2019, <b>8</b>(F1000 Faculty Rev):217 (<a href="https://doi.org/10.12688/f1000research.16497.1" target=_blank>https://doi.org/10.12688/f1000research.16497.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 25 Feb 2019, <b>8</b>(F1000 Faculty Rev):217 (<a href="https://doi.org/10.12688/f1000research.16497.1" target=_blank>https://doi.org/10.12688/f1000research.16497.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e267>Introduction</h2><p class="" id=d13784e270>Male hypogonadism is a clinical syndrome attributed to androgen deficiency (AD). It can detrimentally affect multiple organ functions in addition to having detrimental effects on quality of life in men. Testosterone levels progressively decrease with age<sup><a href="#ref-1">1</a></sup>. After the age of 40 years, testosterone levels in men have been shown to decrease 1 to 2% per year<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. By the seventh decade, 35% of men have been shown to have lower testosterone levels than younger men<sup><a href="#ref-5">5</a></sup>. This has led to the emergence of a group of men older than age 65 years with hypogonadism with so-called “late-onset” hypogonadism (LOH) with its extensive symptom complex including obesity and loss of libido (<a href="#T1">Table 1</a>).</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. “Late-onset” hypogonadism symptom complex.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d13784e302 class=n-a></a><tbody><a name=d13784e304 class=n-a></a><tr><a name=d13784e306 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e307 class=n-a></a>Loss of libido<br class=br>Erectile dysfunction<br class=br>Overweight or obesity<br class=br>Sarcopenia<br class=br>Low bone mineral mass/density<br class=br>Negative mental health impacts, including depression<br class=br>Fatigue<br class=br>Loss of body hair<br class=br>Hot flashes<br class=br>Loss of vigor and frailty<br class=br>Depressive symptoms<br class=br>Poor memory/concentration<br class=br>Reduced lean muscle mass</td></tr></tbody></table></div><p class="" id=d13784e339>Prostate cancer (PCa) remains a significant health burden and cause of male mortality. The National Cancer Institute has estimated that, in the US, over 3 million men are living with PCa<sup><a href="#ref-6">6</a></sup>. It was also estimated that an additional 164,690 cases would be diagnosed in the US during 2018 alone<sup><a href="#ref-6">6</a></sup>. The seminal and Nobel prize–winning study by Huggins and Hodges established the androgen hypothesis in that the growth and progression of PCa are directly related to male androgenic activity when withdrawing these hormones<sup><a href="#ref-7">7</a></sup>. However, nearly 80 years after this publication, there remains controversy and great debate on whether exogenous administration of testosterone will increase the risk of development or the progression of PCa<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. The urgent need for an answer to this is due in part to the sheer volume of the administration of testosterone replacement therapy (TRT), which is now one of the most widely prescribed medications in the US<sup><a href="#ref-10">10</a></sup>. The scientific community still seeks a definitive stance on the oncogenic safety profile of TRT in relation to PCa. In this review, we address the issue of whether there is an association between TRT and PCa by using evidence ranging from basic science to genetic and major epidemiological studies conducted on this topic.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e368>Pathophysiology of androgen-driven prostate cancer</h2><p class="" id=d13784e371>In 1941, Huggins and Hodges demonstrated that testosterone was an oncogenic driving hormone in PCa<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a></sup>. In their study, acid phosphatase activity was elevated in serum specimens of 21 out of 47 PCa cases and 19 out of 25 cases with confirmed bone metastasis<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a></sup>. Eight men who harbored skeletal metastasis then underwent castration<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a></sup>. Their elevated acid phosphatase levels fell rapidly, indicating the androgen dependence of this oncological biomarker<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a></sup>. The subsequent administration of testosterone to these men restored acid phosphatase to a level higher than pre-castration levels<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a></sup>.</p><p class="" id=d13784e409>Owing to their extensive first-pass metabolism through the liver, oral preparations of testosterone are not widely used in TRT<sup><a href="#ref-12">12</a></sup>. Methods of replacement are administered predominantly by transdermal gel or intramuscular depot injection. Testosterone is metabolized to 5α- dihydrotestosterone (DHT), and both testosterone and 5α-DHT contribute to prostatic growth<sup><a href="#ref-12">12</a></sup>. There is abundant evidence that, within an <i>in vitro</i> environment, PCa cell lines are androgen-dependent in that they will undergo apoptosis and reduced cellular proliferation with the withdrawal of this hormone<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. For cell lines, androgens are critical for the development and maintenance of normal and cancer tissue, and the androgen receptor (AR) is the main therapeutic target for PCa<sup><a href="#ref-13">13</a></sup>. This phenomenon is further supported by <i>in vivo</i> studies where the administration of androgens creates a pro-tumorogenic environment in murine xenograft models, and the converse effect follows androgen suppression<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d13784e442>Androgen deprivation therapy (ADT) using gonadotrophin-releasing hormone (GnRH) super-agonists remains the cornerstone of the treatment of metastatic PCa. ADT for the majority of PCas will progress to androgen-independent disease<sup><a href="#ref-16">16</a></sup>. The development of resistance to apoptosis associated with androgen independence is one of the critical later stages of the molecular hallmarks of advanced PCa<sup><a href="#ref-17">17</a></sup>. Several mechanisms have been postulated to explain the transformation of ADT-responsive PCa to castrate-resistant PCa. These include overexpression of the AR, mutations in the AR, altered recruitment of transcription cofactors, and sustained intratumoral synthesis of DHT<sup><a href="#ref-18">18</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e460>Androgen saturation theory</h2><p class="" id=d13784e463>The androgen saturation theory proposes that the effects of testosterone on the prostate are limited by the capacity and concentration of prostate ARs<sup><a href="#ref-19">19</a></sup>. Therefore, testosterone above a given threshold level will have no effect on the prostate<sup><a href="#ref-19">19</a></sup>. In prostatic tissue, the AR becomes saturated at about 4 nmol/L (120 ng/dL) <i>in vitro</i>, corresponding to about 8 nmol/L (240 ng/dL) <i>in vivo</i> because of the presence of binding hormones<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. This model suggests why serum testosterone may appear unrelated to PCa risk in the general population and why testosterone administration in men with metastatic PCa causes rapid progression in castrated but not hormonally intact men<sup><a href="#ref-19">19</a></sup>. This is a significant shift of paradigm from the historical dogma that testosterone drives PCa<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d13784e496>Clinically, this theory was consolidated with the discovery that, although TRT increases serum testosterone levels, it did not correlate with intraprostatic testosterone levels on biopsy specimens of men on TRT<sup><a href="#ref-23">23</a></sup>. Furthermore, in-depth proteomic and genomic analysis of these histological specimens failed to demonstrate an increased expression of PCa-related tissue biomarkers (<i>AR, Ki-67</i>, and <i>CD34</i>) or genes (<i>AR, prostate-specific antigen [PSA], PAP2A, VEGF, NXK3,</i> and <i>CLU [Clusterin</i>])<sup><a href="#ref-23">23</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e523>Testosterone replacement therapy in men without a diagnosis of prostate cancer</h2><p class="" id=d13784e526>The majority of studies on TRT and PCa risk are limited by either insufficient power to determine this risk or their retrospective design (<a href="#T2">Table 2</a>)<sup><a href="#ref-24">24</a></sup>. In 2005, Calof <i>et al</i>.<sup><a href="#ref-25">25</a></sup> reported a meta-analysis of 19 studies, which included 651 men who received TRT, demonstrating that there was no statistically significant difference in PCa diagnoses among those who used testosterone<sup><a href="#ref-25">25</a></sup>. Haider <i>et al</i>.<sup><a href="#ref-26">26</a></sup> reported on a multi-center prospective cohort study consisting of a total of 1023 hypogonadal men who received TRT. With a median follow-up of 5 years, the incidence of PCa was lower in TRT-treated populations than accepted incidence rates from large population-based studies with long-term follow-up<sup><a href="#ref-24">24</a>,<a href="#ref-26">26</a></sup>. The limitations of this study include a younger cohort of patients with a mean age of only 58 years, thus making it challenging to draw comparisons with large screening trials such as Prostate, Lung, Colorectal, and Ovarian (PLCO) and the European Randomized Study of Screening for Prostate Cancer<sup><a href="#ref-27">27</a></sup>. For those men who harbor high-grade prostatic intraepithelial neoplasia (PIN), it has been shown that with short-term follow-up there is no greater risk of an increase of their PSA or PCa compared to those men without PIN<sup><a href="#ref-28">28</a></sup>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Selected studies which support the absence of a link between testosterone replacement therapy and prostate cancer.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d13784e581 class=n-a></a><thead><a name=d13784e583 class=n-a></a><tr><a name=d13784e585 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d13784e586 class=n-a></a>Authors</th><th align=left colspan=1 rowspan=1 valign=top><a name=d13784e589 class=n-a></a>Year</th><th align=left colspan=1 rowspan=1 valign=top><a name=d13784e592 class=n-a></a>Study format</th><th align=left colspan=1 rowspan=1 valign=top><a name=d13784e595 class=n-a></a>Number on<br class=br>testosterone<br class=br>replacement<br class=br>therapy (TRT)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d13784e604 class=n-a></a>Conclusions</th></tr></thead><tbody><a name=d13784e608 class=n-a></a><tr><a name=d13784e610 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e611 class=n-a></a>Loeb <i>et al</i>.<sup><a href="#ref-29">29</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e620 class=n-a></a>2017</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e623 class=n-a></a>Nested case-control</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e626 class=n-a></a>1,662</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e629 class=n-a></a>No overall increase in risk of prostate cancer (PCa). Early increase in<br class=br>the risk of favorable cancer (odds ratio [OR] 1.35, 95% confidence<br class=br>interval [CI] 1.16–1.56) and decrease in the risk of aggressive PCa (OR<br class=br>0.50, 95% CI 0.37–0.67).</td></tr><tr><a name=d13784e638 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e639 class=n-a></a>Haider <i>et al</i>.<sup><a href="#ref-26">26</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e648 class=n-a></a>2015</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e651 class=n-a></a>Prospective cohort<br class=br>(multi-center)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e656 class=n-a></a>1,023</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e659 class=n-a></a>Lower incidence of PCa in TRT-treated populations</td></tr><tr><a name=d13784e662 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e663 class=n-a></a>Eisenberg <i>et al</i>.<sup><a href="#ref-33">33</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e672 class=n-a></a>2015</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e675 class=n-a></a>Retrospective<br class=br>observational</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e680 class=n-a></a>247</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e683 class=n-a></a>There was no change in cancer risk overall, or PCa risk specifically, for<br class=br>men older than 40 years using long-term TRT.</td></tr><tr><a name=d13784e688 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e689 class=n-a></a>Feneley <i>et al</i>.<sup><a href="#ref-34">34</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e698 class=n-a></a>2012</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e701 class=n-a></a>Prospective cohort<br class=br>(single-center)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e706 class=n-a></a>1,365</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e709 class=n-a></a>Incidence of PCa during long-term TRT was equivalent to that of the<br class=br>general population.</td></tr><tr><a name=d13784e714 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e715 class=n-a></a>Calof <i>et al</i>.<sup><a href="#ref-25">25</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e724 class=n-a></a>2005</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e727 class=n-a></a>Meta-analysis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e730 class=n-a></a>651</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e733 class=n-a></a>No statistically significant difference in PCa diagnoses among TRT<br class=br>users</td></tr><tr><a name=d13784e739 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e740 class=n-a></a>Rhoden and<br class=br>Morgentaler<sup><a href="#ref-28">28</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e748 class=n-a></a>2003</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e751 class=n-a></a>Prospective cohort<br class=br>(single-center)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e756 class=n-a></a>75</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e759 class=n-a></a>After 1 year of TRT, men with prostatic intraepithelial neoplasia (PIN)<br class=br>do not have a greater increase in prostate-specific antigen or a<br class=br>significantly increased risk of cancer than men without PIN.</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e772>Contemporary epidemiological studies</h2><p class="" id=d13784e775>A recently published article by Loeb <i>et al</i>.<sup><a href="#ref-29">29</a></sup> reported a large nested case-control study which included over 38,000 and 192, 000 men with diagnosed PCa or free from the disease, respectively. This study demonstrated that there was no overall increase in risk of PCa in those men who received TRT (odds ratio [OR] 1.03, 95% confidence interval [CI] 0.90–1.17). Once the breakdown of disease subtype was analyzed between favorable (T1–T2, PSA &lt;10 ng/mL, Gleason score [GS] ≤6, not N1, no M1) and aggressive (local high risk, T1–T2, GS of 8–10, PSA 20–50 ng/mL, no N1, no M1) disease, locally advanced (T3, PSA &gt;50 ng/mL, not N1, not M1), regionally metastatic (T4, PSA 50–100 ng/mL, N1, no M1), and metastatic (metastases on bone imaging or PSA &gt;100 ng/mL) results demonstrated the clinical benefits of commencing TRT. TRT demonstrated an early increase in favorable-risk PCa (OR 1.35, 95% CI 1.16–1.56), which was balanced with a finding that those men on TRT significantly lowered their risk of harboring aggressive PCas (OR 0.50, 95% CI 0.37–0.67). The vast majority of favorable PCa fell within the spectrum of clinically insignificant PCa<sup><a href="#ref-30">30</a></sup>. There has been a recent shift and drive to change the nomenclature associated with PCa, including calls to drop the label “cancer” with certain favorable-risk PCa<sup><a href="#ref-30">30</a></sup>. Well-characterized pure Gleason grade 3 disease fails to clearly show both clinical and molecular hallmarks that are expected of a cancer. Hence, a strategy that decreases the incidence of aggressive PCa at the expense of its favorable-risk counterpart would warrant further investigation and would be welcomed if robustly proven.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e797>Testosterone replacement therapy with treated prostate cancer</h2><p class="" id=d13784e800>There is now gathering evidence that men who have had their PCa treated by radical prostatectomy (RP) and external beam radiotherapy with curative intent are potentially safe to have TRT administered. However, again, these studies have inherent limitations, including the limited number of patients, the lack of long-term follow-up, and the fact that the study was designed to be a retrospective case series.</p><p class="" id=d13784e803>Kaufman and Graydon reported on seven men who underwent RP and who then were placed on TRT for biochemically confirmed hypogonadism<sup><a href="#ref-31">31</a></sup>. On follow-up of these surgically treated men, no one was found to have either biochemical or clinical recurrence of their malignancy<sup><a href="#ref-31">31</a></sup>. Khera <i>et al</i>.<sup><a href="#ref-32">32</a></sup> reported on a significantly larger cohort of men (n = 57) who underwent RP with confirmed negative surgical margins and subsequently commenced on TRT. With an average follow-up of 13 months (range of 1–99 months), no men in their study demonstrated biochemical recurrence of their cancer with their regular PSA surveillance<sup><a href="#ref-32">32</a></sup>. Similarly, for those men who opted to undergo external beam radiotherapy for their PCa and then commenced on TRT, Pastuszak <i>et al</i>.<sup><a href="#ref-35">35</a></sup> concluded that there was only a minor increase in serum PSA and a low rate of biochemical recurrence in their multi-center series of 98 men<sup><a href="#ref-35">35</a></sup>. The authors also commented that their 6.1% biochemical recurrence was lower than previously reported rates for radiation therapy, suggesting that TRT does not lead to biochemical failure in those men who received radical radiotherapy for their PCa<sup><a href="#ref-35">35</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e844>Testosterone replacement therapy with untreated prostate cancer</h2><p class="" id=d13784e847>A recent systematic review by Kaplan <i>et al</i>.<sup><a href="#ref-36">36</a></sup> highlighted the caution required when commencing TRT for men undergoing active surveillance (AS) or watchful waiting of their PCa as this is “pushing the limits of safety”. This conclusion was based primarily on the sparsity of evidence in this cohort of men with very minimal reports in comparison with those with no diagnosis or treated PCa. Kacker <i>et al</i>.<sup><a href="#ref-37">37</a></sup> recently reported their retrospective study in 28 men on AS for their PCa who commenced TRT for AD in comparison with 96 men in the untreated AD arm. The authors reported that biopsy progression rates were similar between these two groups over a 3-year follow-up period and appear unaffected by TRT<sup><a href="#ref-37">37</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e871>Non-oncological consequences of androgen deficiency</h2><p class="" id=d13784e874>The metabolic syndrome (MetS) was first described in 1923 by Kylin. Later, Reaven coined the term “Syndrome X”, which is a constellation of insulin resistance, hyperglycemia, hypertension, low high-density lipoprotein cholesterol, and increased very-low-density lipoprotein and triglyceride to further define MetS<sup><a href="#ref-38">38</a></sup>. Owing to its associated risk of cardiovascular disease, MetS has been proposed as the main threat to public health in the 21st century<sup><a href="#ref-39">39</a></sup>. There are several definitions of MetS; however, the primary emphasis is on central obesity (<a href="#T3">Table 3</a>), and the estimated prevalence of this among males in the US is 34.5%<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Definition of metabolic syndrome<sup><a href="#ref-41">41</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d13784e910 class=n-a></a><tr><a name=d13784e912 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d13784e914 class=n-a></a>Central abdominal obesity waist circumference of at least 94 cm in Europids<br class=br>and of more than 90 cm in Asians<br class=br>AND</td></tr><tr><a name=d13784e922 class=n-a></a><td align=left colspan=1 rowspan=4 valign=middle><a name=d13784e923 class=n-a></a>2 out of 4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e926 class=n-a></a>elevated triglycerides ≥1.7 mmol/L (≥150 mg/dL)</td></tr><tr><a name=d13784e929 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e931 class=n-a></a>reduced high-density lipoprotein cholesterol &lt;1.03 mmol/L (&lt;40 mg/dL)</td></tr><tr><a name=d13784e934 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e936 class=n-a></a>elevated systolic blood pressure ≥130 mm Hg, diastolic blood pressure<br class=br>≥85 mm Hg (or treatment)</td></tr><tr><a name=d13784e941 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d13784e943 class=n-a></a>dysglycemia (raised fasting plasma glucose, fasting blood glucose<br class=br>≥5.6 mmol/L [≥100 mg/dL]) (or type 2 diabetes mellitus)</td></tr></table></div><p class="" id=d13784e950>There is a strong inverse relationship with testosterone and body fat in men, and numerous epidemiological studies show the increase of MetS with declining testosterone levels<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>. The central fat seen with abdominal obesity has high aromatase activity converting testosterone to estradiol<sup><a href="#ref-43">43</a></sup>. Furthermore, testosterone promotes lipolysis and inhibits adipocyte development<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d13784e968>About 50% of men with diagnosed PCa will be exposed to ADT at some stage of their disease<sup><a href="#ref-44">44</a></sup>. Again, the clinical adverse effects of low testosterone due to ADT are well reported and have a negative effect on quality of life<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. ADT in those with PCa has been linked to a metabolic-type syndrome of insulin insensitivity with its associated central obesity and decreased muscle mass<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d13784e987>Numerous interventional studies have shown that TRT in hypogonadal men with MetS has beneficial effects on central adiposity, insulin resistance, and glycemic control<sup><a href="#ref-43">43</a>,<a href="#ref-47">47</a></sup>. In addition, TRT has shown improvements in well-established cardiovascular risk factors by lowering elevated blood pressure, triglyceride levels, and cholesterol<sup><a href="#ref-43">43</a></sup>. TRT has also been shown, in a prospective manner, to address the detrimental sexual dysfunction associated with LOH<sup><a href="#ref-48">48</a></sup>. The administration or TRT has been shown to result in a significant improvement in the various aspects of sexual function, including sexual desire, intercourse satisfaction, and overall satisfaction<sup><a href="#ref-48">48</a></sup>. Similarly, TRT has demonstrated significant improvement in depressive symptoms in those who received treatment within the setting of a randomized trial<sup><a href="#ref-49">49</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e1016>Commercial caution</h2><p class="" id=d13784e1019>TRT drugs have been a phenomenal commercial success and their pharmaceutical sales are rising year-on-year<sup><a href="#ref-10">10</a></sup>. The off-label indications have led to an exponential increase in the prescription of TRT in the US, and commercial marketing efforts are potentially linked to prescriber habits<sup><a href="#ref-50">50</a></sup>. This increased commercialism had included the use of TRT without the clinical or biochemical confirmation of hypogonadism, and there are calls to limit overtreatment with the application of strict diagnostic criteria of LOH<sup><a href="#ref-50">50</a></sup>. Alarmingly, there has been a fourfold increase in the use TRT in the younger cohort of men (18–45 years) in the US<sup><a href="#ref-51">51</a></sup>. This has potential clinical implications—not the least of which is the potential detrimental effect on fertility in this age group—that may not manifest until after several decades. This increased use in younger men would require future focused studies assessing the long-term oncological sequelae of early TRT use. Crucially, the potential oncological manifestations of TRT use in younger men may not reveal themselves for several decades.</p><p class="" id=d13784e1038>Testosterone dependence has also been identified<sup><a href="#ref-52">52</a></sup>. The cessation of TRT ultimately will result in the restoration of baseline serum testosterone levels; however, these men may feel markedly symptomatic and seek additional testosterone while waiting for normal levels to be achieved<sup><a href="#ref-52">52</a></sup>. The current European Association of Urology guidelines on male hypogonadism advocate the use of TRT, including in those adult men with consistent and preferably multiple signs and symptoms of hypogonadism and a low testosterone following unsuccessful treatment of obesity and comorbidities.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13784e1052>Conclusions</h2><p class="" id=d13784e1055>With the increased use of TRT for the treatment of AD, it is essential that the clinician be well versed in its potential oncological implications. At present, there is no definitive evidence that administration of exogenous testosterone will increase the incidence of PCa. The absence of a large randomized clinical trial to address this topic is starkly obvious; such a study is vital before we can confidently counsel men who express interest in or harbor a clinical need for TRT. At best, we can provide these men only sub–level 1 evidence of TRT in relation to PCa, highlighting the ambiguity and dearth of high-quality studies. In our clinical practice, when prescribing TRT, we make it paramount that patients be made aware that, although there may be a significant improvement in the signs and symptoms of LOH, the unlikely risk of developing a significant <i>de novo</i> or recurrence of their treated PCa as a direct result of pharmacological intervention is currently based on less-than-optimal data. When we are faced with those men with untreated PCa or on AS, we avoid TRT at present. However, we eagerly await further evidence that would suggest otherwise.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d13784e1 class=n-a></a><h2 class=main-title id=d13929>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d13784e1065 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d14093>References</h2><div class="section ref-list"><a name=d13784e1065 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730269303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1072 class=n-a></a>McBride JA, Carson CC 3rd, Coward RM: Testosterone deficiency in the aging male. <i>Ther Adv Urol.</i> 2016; <b>8</b>(1): 47–60. <a target=xrefwindow id=d13784e1080 href="http://www.ncbi.nlm.nih.gov/pubmed/26834840">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1083 href="https://doi.org/10.1177/1756287215612961">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1086 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4707424">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730269303">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d13784e1099 class=n-a></a>Harman SM, Metter EJ, Tobin JD, <i> et al.</i>: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. <i>J Clin Endocrinol Metab.</i> 2001; <b>86</b>(2): 724–31. <a target=xrefwindow id=d13784e1110 href="http://www.ncbi.nlm.nih.gov/pubmed/11158037">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1113 href="https://doi.org/10.1210/jcem.86.2.7219">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d13784e1122 class=n-a></a>Kaufman JM, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. <i>Endocr Rev.</i> 2005; <b>26</b>(6): 833–76. <a target=xrefwindow id=d13784e1130 href="http://www.ncbi.nlm.nih.gov/pubmed/15901667">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1133 href="https://doi.org/10.1210/er.2004-0013">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d13784e1142 class=n-a></a>Wu FC, Tajar A, Pye SR, <i> et al.</i>: Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. <i>J Clin Endocrinol Metab.</i> 2008; <b>93</b>(7): 2737–45. <a target=xrefwindow id=d13784e1153 href="http://www.ncbi.nlm.nih.gov/pubmed/18270261">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1156 href="https://doi.org/10.1210/jc.2007-1972">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d13784e1165 class=n-a></a>Vermeulen A, Kaufman JM: Ageing of the hypothalamo-pituitary-testicular axis in men. <i>Horm Res.</i> 1995; <b>43</b>(1–3): 25–8. <a target=xrefwindow id=d13784e1173 href="http://www.ncbi.nlm.nih.gov/pubmed/7721258">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1176 href="https://doi.org/10.1159/000184233">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d13784e1186 class=n-a></a>Noone AH, Krapcho N, Miller M, <i> et al.</i>: SEER Cancer Statistics Review, 1975-2015. <i>National cancer Institute</i>. 2018. <a target=xrefwindow id=d13784e1194 href="https://seer.cancer.gov/csr/1975_2015/">Reference Source</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d13784e1203 class=n-a></a>Huggins C, Hodges CV: The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate. <i>Cancer Res.</i> 1941; <b>1</b>(4): 293–97. <a target=xrefwindow id=d13784e1211 href="http://cancerres.aacrjournals.org/content/canres/1/4/293.full.pdf">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726663438"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1220 class=n-a></a>Morgentaler A: Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro. <i>J Urol.</i> 2016; <b>196</b>(4): 985–8. <a target=xrefwindow id=d13784e1228 href="http://www.ncbi.nlm.nih.gov/pubmed/27449261">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1231 href="https://doi.org/10.1016/j.juro.2016.07.075">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726663438">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726663437"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1244 class=n-a></a>Gleave ME, Klotz L: Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Con. <i>J Urol.</i> 2016; <b>196</b>(4): 985–8. <a target=xrefwindow id=d13784e1252 href="http://www.ncbi.nlm.nih.gov/pubmed/27520085">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1255 href="https://doi.org/10.1016/j.juro.2016.08.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726663437">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d13784e1268 class=n-a></a>Busnelli A, Somigliana E, Vercellini P: 'Forever Young'-Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises. <i>Hum Reprod.</i> 2017; <b>32</b>(4): 719–24. <a target=xrefwindow id=d13784e1276 href="http://www.ncbi.nlm.nih.gov/pubmed/28333214">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1279 href="https://doi.org/10.1093/humrep/dex032">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726079450"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1288 class=n-a></a>Nelson WG: Commentary on Huggins and Hodges: “Studies on Prostatic Cancer”. <i>Cancer Res.</i> 2016; <b>76</b>(2): 186–7. <a target=xrefwindow id=d13784e1296 href="http://www.ncbi.nlm.nih.gov/pubmed/26773095">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1299 href="https://doi.org/10.1158/0008-5472.CAN-15-3172">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726079450">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727213690"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1313 class=n-a></a>Shoskes JJ, Wilson MK, Spinner ML: Pharmacology of testosterone replacement therapy preparations. <i>Transl Androl Urol.</i> 2016; <b>5</b>(6): 834–43. <a target=xrefwindow id=d13784e1321 href="http://www.ncbi.nlm.nih.gov/pubmed/28078214">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1324 href="https://doi.org/10.21037/tau.2016.07.10">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1327 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5182226">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727213690">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d13784e1340 class=n-a></a>Marchiani S, Tamburrino L, Nesi G, <i> et al.</i>: Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation. <i>Int J Androl.</i> 2010; <b>33</b>(6): 784–93. <a target=xrefwindow id=d13784e1351 href="http://www.ncbi.nlm.nih.gov/pubmed/20088946">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1354 href="https://doi.org/10.1111/j.1365-2605.2009.01030.x">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d13784e1363 class=n-a></a>Kyprianou N, English HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. <i>Cancer Res.</i> 1990; <b>50</b>(12): 3748–53. <a target=xrefwindow id=d13784e1371 href="http://www.ncbi.nlm.nih.gov/pubmed/2340521">PubMed Abstract </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d13784e1380 class=n-a></a>Ahmad I, Sansom OJ, Leung HY: Advances in mouse models of prostate cancer. <i>Expert Rev Mol Med.</i> 2008; <b>10</b>: e16. <a target=xrefwindow id=d13784e1388 href="http://www.ncbi.nlm.nih.gov/pubmed/18538039">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1391 href="https://doi.org/10.1017/S1462399408000689">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d13784e1400 class=n-a></a>Arnold JT, Isaacs JT: Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. <i>Endocr Relat Cancer.</i> 2002; <b>9</b>(1): 61–73. <a target=xrefwindow id=d13784e1408 href="http://www.ncbi.nlm.nih.gov/pubmed/11914183">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4124629">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9499956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1420 class=n-a></a>Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. <i>Cell.</i> 2011; <b>144</b>(5): 646–74. <a target=xrefwindow id=d13784e1428 href="http://www.ncbi.nlm.nih.gov/pubmed/21376230">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1431 href="https://doi.org/10.1016/j.cell.2011.02.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9499956">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d13784e1445 class=n-a></a>Chang KH, Ercole CE, Sharifi N: Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences. <i>Br J Cancer.</i> 2014; <b>111</b>(7): 1249–54. <a target=xrefwindow id=d13784e1453 href="http://www.ncbi.nlm.nih.gov/pubmed/24867689">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1456 href="https://doi.org/10.1038/bjc.2014.268">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1459 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4183835">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d13784e1468 class=n-a></a>Morgentaler A: Testosterone therapy in men with prostate cancer: scientific and ethical considerations. <i>J Urol.</i> 2013; <b>189</b>(1 Suppl): S26–33. <a target=xrefwindow id=d13784e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/23234627">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1479 href="https://doi.org/10.1016/j.juro.2012.11.028">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d13784e1488 class=n-a></a>Traish AM, Williams DF, Hoffman ND, <i> et al.</i>: Validation of the exchange assay for the measurement of androgen receptors in human and dog prostates. <i>Prog Clin Biol Res.</i> 1988; <b>262</b>: 145–60. <a target=xrefwindow id=d13784e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/3375279">PubMed Abstract </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d13784e1508 class=n-a></a>Traish AM, Muller RE, Wotiz HH: A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors. <i>J Biol Chem.</i> 1981; <b>256</b>(23): 12028–33. <a target=xrefwindow id=d13784e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/6975277">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735112639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1525 class=n-a></a>Bell MA, Campbell JD, Joice G, <i> et al.</i>: Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer. <i>World J Mens Health.</i> 2018; <b>36</b>(2): 103–9. <a target=xrefwindow id=d13784e1536 href="http://www.ncbi.nlm.nih.gov/pubmed/29623698">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1539 href="https://doi.org/10.5534/wjmh.170007">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1543 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5924951">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735112639">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1050553"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1556 class=n-a></a>Marks LS, Mazer NA, Mostaghel E, <i> et al.</i>: Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. <i>JAMA.</i> 2006; <b>296</b>(19): 2351–61. <a target=xrefwindow id=d13784e1567 href="http://www.ncbi.nlm.nih.gov/pubmed/17105798">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1570 href="https://doi.org/10.1001/jama.296.19.2351">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1050553">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d13784e1584 class=n-a></a>Michaud JE, Billups KL, Partin AW: Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk. <i>Ther Adv Urol.</i> 2015; <b>7</b>(6): 378–87. <a target=xrefwindow id=d13784e1592 href="http://www.ncbi.nlm.nih.gov/pubmed/26622322">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1595 href="https://doi.org/10.1177/1756287215597633">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1598 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4647137">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d13784e1607 class=n-a></a>Calof OM, Singh AB, Lee ML, <i> et al.</i>: Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. <i>J Gerontol A Biol Sci Med Sci.</i> 2005; <b>60</b>(11): 1451–7. <a target=xrefwindow id=d13784e1618 href="http://www.ncbi.nlm.nih.gov/pubmed/16339333">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1621 href="https://doi.org/10.1093/gerona/60.11.1451">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718475709"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1630 class=n-a></a>Haider A, Zitzmann M, Doros G, <i> et al.</i>: Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. <i>J Urol.</i> 2015; <b>193</b>(1): 80–6. <a target=xrefwindow id=d13784e1641 href="http://www.ncbi.nlm.nih.gov/pubmed/24980615">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1644 href="https://doi.org/10.1016/j.juro.2014.06.071">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718475709">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d13784e1657 class=n-a></a>Butler P, Scovell JM, Ramasamy R, <i> et al.</i>: Words of Wisdom. Re: Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. <i>Eur Urol.</i> 2015; <b>67</b>(6): 1186–7. <a target=xrefwindow id=d13784e1668 href="http://www.ncbi.nlm.nih.gov/pubmed/25944034">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1671 href="https://doi.org/10.1016/j.eururo.2015.02.014">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d13784e1680 class=n-a></a>Rhoden EL, Morgentaler A: Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. <i>J Urol.</i> 2003; <b>170</b>(6 Pt 1): 2348–51. <a target=xrefwindow id=d13784e1688 href="http://www.ncbi.nlm.nih.gov/pubmed/14634413">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1691 href="https://doi.org/10.1097/01.ju.0000091104.71869.8e">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727565137"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1700 class=n-a></a>Loeb S, Folkvaljon Y, Damber JE, <i> et al.</i>: Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer. <i>J Clin Oncol.</i> 2017; <b>35</b>(13): 1430–6. <a target=xrefwindow id=d13784e1711 href="http://www.ncbi.nlm.nih.gov/pubmed/28447913">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1714 href="https://doi.org/10.1200/JCO.2016.69.5304">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455459">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727565137">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d13784e1732 class=n-a></a>Miah S, Ahmed HU, Freeman A, <i> et al.</i>: Does true Gleason pattern 3 merit its cancer descriptor? <i>Nat Rev Urol.</i> 2016; <b>13</b>(9): 541–8. <a target=xrefwindow id=d13784e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/27530265">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1746 href="https://doi.org/10.1038/nrurol.2016.141">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d13784e1755 class=n-a></a>Kaufman JM, Graydon RJ: Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. <i>J Urol.</i> 2004; <b>172</b>(3): 920–2. <a target=xrefwindow id=d13784e1763 href="http://www.ncbi.nlm.nih.gov/pubmed/15310998">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1766 href="https://doi.org/10.1097/01.ju.0000136269.10161.32">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d13784e1775 class=n-a></a>Khera M, Grober ED, Najari B, <i> et al.</i>: Testosterone replacement therapy following radical prostatectomy. <i>J Sex Med.</i> 2009; <b>6</b>(4): 1165–70. <a target=xrefwindow id=d13784e1786 href="http://www.ncbi.nlm.nih.gov/pubmed/19207277">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1789 href="https://doi.org/10.1111/j.1743-6109.2009.01161.x">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718333907"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1798 class=n-a></a>Eisenberg ML, Li S, Betts P, <i> et al.</i>: Testosterone therapy and cancer risk. <i>BJU Int.</i> 2015; <b>115</b>(2): 317–21. <a target=xrefwindow id=d13784e1809 href="http://www.ncbi.nlm.nih.gov/pubmed/24684569">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1812 href="https://doi.org/10.1111/bju.12756">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718333907">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d13784e1825 class=n-a></a>Feneley MR, Carruthers M: Is testosterone treatment good for the prostate? Study of safety during long-term treatment. <i>J Sex Med.</i> 2012; <b>9</b>(8): 2138–49. <a target=xrefwindow id=d13784e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/22672563">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1836 href="https://doi.org/10.1111/j.1743-6109.2012.02808.x">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725525394"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1845 class=n-a></a>Pastuszak AW, Khanna A, Badhiwala N, <i> et al.</i>: Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. <i>J Urol.</i> 2015; <b>194</b>(5): 1271–6. <a target=xrefwindow id=d13784e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/26025500">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1859 href="https://doi.org/10.1016/j.juro.2015.05.084">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725525394">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726048275"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e1873 class=n-a></a>Kaplan AL, Hu JC, Morgentaler A, <i> et al.</i>: Testosterone Therapy in Men With Prostate Cancer. <i>Eur Urol.</i> 2016; <b>69</b>(5): 894–903. <a target=xrefwindow id=d13784e1884 href="http://www.ncbi.nlm.nih.gov/pubmed/26719015">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1887 href="https://doi.org/10.1016/j.eururo.2015.12.005">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5000551">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726048275">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d13784e1904 class=n-a></a>Kacker R, Hult M, San Francisco IF, <i> et al.</i>: Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results. <i>Asian J Androl.</i> 2016; <b>18</b>(1): 16–20. <a target=xrefwindow id=d13784e1915 href="http://www.ncbi.nlm.nih.gov/pubmed/26306850">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1918 href="https://doi.org/10.4103/1008-682X.160270">Publisher Full Text </a> | <a target=xrefwindow id=d13784e1922 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4736350">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d13784e1931 class=n-a></a>Reaven GM: Role of insulin resistance in human disease (syndrome X): an expanded definition. <i>Annu Rev Med.</i> 1993; <b>44</b>: 121–31. <a target=xrefwindow id=d13784e1939 href="http://www.ncbi.nlm.nih.gov/pubmed/8476236">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1942 href="https://doi.org/10.1146/annurev.me.44.020193.001005">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d13784e1951 class=n-a></a>Taskinen MR: Is metabolic syndrome the main threat to human health in the twenty-first century? <i>Arterioscler Thromb Vasc Biol.</i> 2007; <b>27</b>(11): 2275. <a target=xrefwindow id=d13784e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/17901371">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1962 href="https://doi.org/10.1161/ATVBAHA.107.154195">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d13784e1971 class=n-a></a>Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. <i>Diabetes Care.</i> 2005; <b>28</b>(11): 2745–9. <a target=xrefwindow id=d13784e1979 href="http://www.ncbi.nlm.nih.gov/pubmed/16249550">PubMed Abstract </a> | <a target=xrefwindow id=d13784e1982 href="https://doi.org/10.2337/diacare.28.11.2745">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d13784e1991 class=n-a></a>Alberti KG, Zimmet P, Shaw J: Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. <i>Diabet Med.</i> 2006; <b>23</b>(5): 469–80. <a target=xrefwindow id=d13784e1999 href="http://www.ncbi.nlm.nih.gov/pubmed/16681555">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2002 href="https://doi.org/10.1111/j.1464-5491.2006.01858.x">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d13784e2012 class=n-a></a>Kapoor D, Malkin CJ, Channer KS, <i> et al.</i>: Androgens, insulin resistance and vascular disease in men. <i>Clin Endocrinol (Oxf).</i> 2005; <b>63</b>(3): 239–50. <a target=xrefwindow id=d13784e2023 href="http://www.ncbi.nlm.nih.gov/pubmed/16117808">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2026 href="https://doi.org/10.1111/j.1365-2265.2005.02299.x">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d13784e2035 class=n-a></a>Salam R, Kshetrimayum AS, Keisam R: Testosterone and metabolic syndrome: The link. <i>Indian J Endocrinol Metab.</i> 2012; <b>16 Suppl 1</b>: S12–9. <a target=xrefwindow id=d13784e2043 href="http://www.ncbi.nlm.nih.gov/pubmed/22701831">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2046 href="https://doi.org/10.4103/2230-8210.94248">Publisher Full Text </a> | <a target=xrefwindow id=d13784e2049 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3354945">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727743113"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e2058 class=n-a></a>Gunner C, Gulamhusein A, Rosario DJ: The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer. <i>J Clin Urol.</i> 2016; <b>9</b>(2 Suppl): 24–9. <a target=xrefwindow id=d13784e2066 href="http://www.ncbi.nlm.nih.gov/pubmed/28344813">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2069 href="https://doi.org/10.1177/2051415816654048">Publisher Full Text </a> | <a target=xrefwindow id=d13784e2072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5356175">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727743113">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718521683"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e2085 class=n-a></a>Nguyen PL, Alibhai SM, Basaria S, <i> et al.</i>: Adverse effects of androgen deprivation therapy and strategies to mitigate them. <i>Eur Urol.</i> 2015; <b>67</b>(5): 825–36. <a target=xrefwindow id=d13784e2096 href="http://www.ncbi.nlm.nih.gov/pubmed/25097095">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2099 href="https://doi.org/10.1016/j.eururo.2014.07.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718521683">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d13784e2112 class=n-a></a>Herr HW, O’Sullivan M: Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. <i>J Urol.</i> 2000; <b>163</b>(6): 1743–6. <a target=xrefwindow id=d13784e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/10799173">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2123 href="https://doi.org/10.1016/S0022-5347(05)67533-7">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d13784e2132 class=n-a></a>Kapoor D, Goodwin E, Channer KS, <i> et al.</i>: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. <i>Eur J Endocrinol.</i> 2006; <b>154</b>(6): 899–906. <a target=xrefwindow id=d13784e2143 href="http://www.ncbi.nlm.nih.gov/pubmed/16728551">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2146 href="https://doi.org/10.1530/eje.1.02166">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d13784e2156 class=n-a></a>Moon DG, Park MG, Lee SW, <i> et al.</i>: The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study. <i>J Sex Med.</i> 2010; <b>7</b>(6): 2253–60. <a target=xrefwindow id=d13784e2167 href="http://www.ncbi.nlm.nih.gov/pubmed/20345732">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2170 href="https://doi.org/10.1111/j.1743-6109.2010.01765.x">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d13784e2179 class=n-a></a>Giltay EJ, Tishova YA, Mskhalaya GJ, <i> et al.</i>: Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. <i>J Sex Med.</i> 2010; <b>7</b>(7): 2572–82. <a target=xrefwindow id=d13784e2190 href="http://www.ncbi.nlm.nih.gov/pubmed/20524974">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2193 href="https://doi.org/10.1111/j.1743-6109.2010.01859.x">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d13784e2202 class=n-a></a>Bandari J, Ayyash OM, Emery SL, <i> et al.</i>: Marketing and Testosterone Treatment in the USA: A Systematic Review. <i>Eur Urol Focus.</i> 2017; <b>3</b>(4–5): 395–402. <a target=xrefwindow id=d13784e2213 href="http://www.ncbi.nlm.nih.gov/pubmed/29174614">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2216 href="https://doi.org/10.1016/j.euf.2017.10.016">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726901135"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e2225 class=n-a></a>Rao PK, Boulet SL, Mehta A, <i> et al.</i>: Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States. <i>J Urol.</i> 2017; <b>197</b>(4): 1121–6. <a target=xrefwindow id=d13784e2236 href="http://www.ncbi.nlm.nih.gov/pubmed/27789218">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2239 href="https://doi.org/10.1016/j.juro.2016.10.063">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726901135">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717968214"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d13784e2252 class=n-a></a>Kim ED, Crosnoe L, Bar-Chama N, <i> et al.</i>: The treatment of hypogonadism in men of reproductive age. <i>Fertil Steril.</i> 2013; <b>99</b>(3): 718–24. <a target=xrefwindow id=d13784e2263 href="http://www.ncbi.nlm.nih.gov/pubmed/23219010">PubMed Abstract </a> | <a target=xrefwindow id=d13784e2266 href="https://doi.org/10.1016/j.fertnstert.2012.10.052">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717968214">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Feb 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-217/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-217/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK<br/> <sup>2</sup> Division of Surgery and Interventional Science, University College London Medical School, 21 University Street, London, WC1E 6AU, UK<br/> <sup>3</sup> Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, SW7 2AZ, UK<br/> <sup>4</sup> Section of Investigative Medicine, Department of Medicine, Imperial College London, London, W12 0NN, UK<br/> <p> <div class=margin-bottom> Saiful Miah <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Tharu Tharakan <br/> <span>Roles: </span> Data Curation, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Kylie A Gallagher <br/> <span>Roles: </span> Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Taimur T Shah <br/> <span>Roles: </span> Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mathias Winkler <br/> <span>Roles: </span> Methodology, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Channa N Jayasena <br/> <span>Roles: </span> Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Hashim U Ahmed <br/> <span>Roles: </span> Supervision, Writing – Review & Editing </div> <div class=margin-bottom> Suks Minhas <br/> <span>Roles: </span> Conceptualization, Formal Analysis, Methodology, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-217/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 25 Feb 2019, 8:217 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16497.1">https://doi.org/10.12688/f1000research.16497.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Miah S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=18031 data-id=16497 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16497.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-217/v1/pdf?article_uuid=8a9eb659-9a77-4cbf-96cf-7e33010675e4" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16497.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Miah S, Tharakan T, Gallagher KA <em>et al.</em> The effects of testosterone replacement therapy on the prostate: a clinical perspective [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):217 (<a href="https://doi.org/10.12688/f1000research.16497.1" target=_blank>https://doi.org/10.12688/f1000research.16497.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16497 id=mobile-track-article-signin-16497 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16497?target=/articles/8-217/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18031 /> <input name=articleId type=hidden value=16497 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ates Kad&#305;o&#287;lu</strong>, Section of Andrology, Department of Urology, University of Istanbul, School of Medicine, Turkey </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Ya&#351;ar Pazir</strong>, Department of Urology, University of Istanbul, Turkey </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Larry I. Lipshultz</strong>, Center for Reproductive Medicine, Baylor College of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Feb 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-217/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-217/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27265-44695></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15921-44696></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-217/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>25 Feb 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ates Kad&#305;o&#287;lu</strong>, Section of Andrology, Department of Urology, University of Istanbul, School of Medicine, Turkey </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Ya&#351;ar Pazir</strong>, Department of Urology, University of Istanbul, Turkey </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Larry I. Lipshultz</strong>, Center for Reproductive Medicine, Baylor College of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-217/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-217/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The effects of testosterone replacement therapy...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-217/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-217/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-217/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Miah S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-217/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-217",
            templates : {
                twitter : "The effects of testosterone replacement therapy on the prostate:.... Miah S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-217/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The effects of testosterone replacement therapy on the prostate: a clinical perspective", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The effects of testosterone replacement therapy on the prostate: a clinical perspective", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16497/18031")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "18031");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "44695": 0,
                           "44696": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e0804bfb-c064-4fbe-bf45-d77635a41656";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-217.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-217.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-217.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-217.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-217.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>